Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients.
about
Image guided surgery for the resection of brain tumoursIn vivo bio-imaging using chlorotoxin-based conjugatesThe Art of Intraoperative Glioma Identification.Treating malignant glioma in Chinese patients: update on temozolomideRegulation of development and cancer by the R2B subfamily of RPTPs and the implications of proteolysisAdjuncts for maximizing resection: 5-aminolevuinic acidPhase 1/2 trials of Temozolomide, Motexafin Gadolinium, and 60-Gy fractionated radiation for newly diagnosed supratentorial glioblastoma multiforme: final results of RTOG 0513.Porphyrins as theranostic agents from prehistoric to modern times.Topical application of activity-based probes for visualization of brain tumor tissueThe role of 5-aminolevulinic acid in enhancing surgery for high-grade glioma, its current boundaries, and future perspectives: A systematic review.Through the patient's eyes: an emphasis on patient-centered values in operative decision making in the management of malignant glioma.Treatment of glioblastoma in elderly patients.The value of extent of resection of glioblastomas: clinical evidence and current approach.Intraoperative assistive technologies and extent of resection in glioma surgery: a systematic review of prospective controlled studies.Survival following reirradiation using intensity-modulated radiation therapy with temozolomide in selected patients with recurrent high grade gliomasIntraoperative fluorescence-guided resection of high-grade malignant gliomas using 5-aminolevulinic acid-induced porphyrins: a systematic review and meta-analysis of prospective studiesBevacizumab-related toxicities in the National Cancer Institute malignant glioma trial cohort.Current data and strategy in glioblastoma multiformeEstimation of brain deformation for volumetric image updating in protoporphyrin IX fluorescence-guided resectionFluorescence-guided surgery and biopsy in gliomas with an exoscope system.Intratumor administration of the photosensitizer pc 4 affords photodynamic therapy efficacy and selectivity at short drug-light intervalsComparative Study of Adjuvant Temozolomide Six Cycles Versus Extended 12 Cycles in Newly Diagnosed Glioblastoma MultiformeQuantitative fluorescence in intracranial tumor: implications for ALA-induced PpIX as an intraoperative biomarker.Deferoxamine iron chelation increases delta-aminolevulinic acid induced protoporphyrin IX in xenograft glioma model.Glioblastoma: changing expectations?A Phase II trial of tandutinib (MLN 518) in combination with bevacizumab for patients with recurrent glioblastoma.Tumour-infiltrating T-cell subpopulations in glioblastomas.δ-aminolevulinic acid-induced protoporphyrin IX concentration correlates with histopathologic markers of malignancy in human gliomas: the need for quantitative fluorescence-guided resection to identify regions of increasing malignancyReview of Neurosurgical Fluorescence Imaging Methodologies.Prognostic factors and survival in a prospective cohort of patients with high-grade glioma treated with carmustine wafers or temozolomide on an intention-to-treat basis.Long-Term Survival of a Patient with Giant Cell Glioblastoma: Case Report and Review of the LiteratureCoregistered fluorescence-enhanced tumor resection of malignant glioma: relationships between δ-aminolevulinic acid-induced protoporphyrin IX fluorescence, magnetic resonance imaging enhancement, and neuropathological parameters. Clinical article.Experimental approaches for the treatment of malignant gliomas.Oncological patterns of care and outcome for 952 patients with newly diagnosed glioblastoma in 2004.Glioblastoma multiforme treatment with clinical trials for surgical resection (aminolevulinic acid).RTOG 0211: a phase 1/2 study of radiation therapy with concurrent gefitinib for newly diagnosed glioblastoma patients.The prognosis of anaplastic astrocytoma with radiologic necrosis mimicking glioblastoma.5-Aminolevulinic acid-derived tumor fluorescence: the diagnostic accuracy of visible fluorescence qualities as corroborated by spectrometry and histology and postoperative imaging.Can MRI-derived factors predict the survival in glioblastoma patients treated with postoperative chemoradiation therapy?Current and future clinical applications for optical imaging of cancer: from intraoperative surgical guidance to cancer screening
P2860
Q24200959-704AEB45-02FD-4730-87D0-BAF99434669DQ24595399-28BD1FC5-5943-4B41-954A-787B164EC0F3Q26797281-E3EAC8BC-5EA6-4322-BEAC-9A7F89BCD816Q26863755-C178D447-B8A0-48E9-A11A-908463D7E0EEQ26865296-5037AB7F-71BF-4A6A-AAB0-508572DA66F0Q26999253-3F688711-EB38-442A-B003-266DCB4F4FF0Q27310843-7BD4FE51-888F-4197-A5A8-B8538C475D72Q28716876-94A9CFEB-F3BC-4211-AF77-EDEA20749C05Q28731330-41B6416D-020C-4015-859C-13100665E2B8Q30250298-7F2EB130-062D-4FB6-B643-BC38E0F50282Q30363967-1B14E71D-6721-4A6C-99D3-49791BCD4C3FQ30838145-5A8A06BF-A9B9-44C7-B753-C33A7F607AA1Q30873962-AA408169-6F68-4FE2-8D43-E9AA001076BFQ30873985-B0963E2D-B664-4546-B101-9E7C705865A5Q31033595-12405D00-B0DF-4A68-889B-42390D1A2900Q31118506-80B65D0A-D665-407A-A177-4F37CF58FD65Q33416917-2D609CD3-2215-4A42-80B5-DEB44F97AB51Q33527073-02EDE5E1-664F-42B0-BEF3-1BA0AADE0F20Q33620235-38F32C60-66E2-43B3-8C88-1710D98CCC23Q33747371-1B01D6AC-846D-48D2-BF3F-067167194295Q33760618-1788BF44-124C-4BB0-AF8A-5FB15F37AA85Q33832441-BD6A5C68-4078-45DE-9C01-256BEFE8E3A2Q33856249-96B1AA59-DBD2-4E95-ACFE-E054482F128AQ33872581-9B3FA9A9-0E37-45A2-8004-920BAB2D3288Q33873093-9AE42C79-AA4B-4CA1-8629-CDB557B0C8A6Q33913465-B3BC597C-F816-434A-9E64-8FD6F0BEE768Q33943553-F643B323-E0A2-48D5-A437-7C34EA82732FQ33974708-23E51ECD-4B14-44CA-95ED-25189F785805Q34023717-9749E80A-BF35-4236-975F-61E4247A053EQ34048935-3C42FC71-68A1-45EA-ACEF-2F2B8A3FB57FQ34054790-8B530B94-1BA4-40A3-9A1A-9D23A36B9E22Q34063357-3C774AEF-55F5-4951-9DC7-0D000DEE8728Q34127138-C6AE27FC-1EF3-4751-92BF-32C9319D332EQ34132971-8DC4C8BC-C821-4E94-BFB5-579CE1B727E5Q34322841-21C0A65A-EAE2-4884-AB8A-AB7B9A3CF4CCQ34349820-595586B7-AB3C-40E4-9918-558FCE8B70EBQ34349906-91D81F53-6EF8-47FE-A87D-98903DB71BBBQ34387771-9A5CEE22-FE97-47B2-848D-E8546F9C912BQ34471323-90E7019E-33A7-4311-9188-29429B3409A2Q34700347-8927AAF8-1052-4E1C-B663-0EBE0C591736
P2860
Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Resection and survival in glio ...... nalysis of ALA study patients.
@ast
Resection and survival in glio ...... nalysis of ALA study patients.
@en
type
label
Resection and survival in glio ...... nalysis of ALA study patients.
@ast
Resection and survival in glio ...... nalysis of ALA study patients.
@en
prefLabel
Resection and survival in glio ...... nalysis of ALA study patients.
@ast
Resection and survival in glio ...... nalysis of ALA study patients.
@en
P2093
P2860
P1433
P1476
Resection and survival in glio ...... nalysis of ALA study patients.
@en
P2093
ALA Glioma Study Group
Andrea Bink
Gabriele Schackert
Uwe Pichlmeier
Walter Stummer
P2860
P304
P356
10.1215/15228517-2008-052
P577
2008-07-30T00:00:00Z